Pierre Fabre Medicament
Manufacturer / marketing-authorisation holder
Pierre Fabre Medicament — 21 products across 2 markets, 9 brand names. Products are grouped by country; brand names link to their brand page and ingredients to the ingredient or combination page. It is the marketing-authorisation holder recorded by the regulator, not necessarily the factory.
Pierre Fabre Medicament — 21 productos en 2 mercados, 9 nombres comerciales. Los productos se agrupan por país; los nombres comerciales enlazan a su página de marca y los principios activos a la página del principio o de la combinación. Es el titular registrado por el regulador, no necesariamente la fábrica.
Pierre Fabre Medicament —— 共 21 个产品,覆盖 2 个市场、9 个品牌名。产品按国家分组;品牌名链到品牌页,成分链到成分页/组合页。这里记录的是监管数据里的「上市许可持有人」,不一定是生产工厂。
21 products · 2 markets · 9 brand names
21 productos · 2 mercados · 9 marcas
21 个产品 · 2 个市场 · 9 个品牌名
Products by country
ES
Source: cima.aemps.es
| Brand | Active ingredient(s) | Form |
|---|---|---|
| BRAFTOVI | Encorafenib | capsule |
| BRAFTOVI | Encorafenib | capsule |
| BUSILVEX | 白消安 | injection |
| EBVALLO × 10E7 × 10E7 CÉLULAS | Tabelecleucel | injection |
| HEMANGIOL | 盐酸普萘洛尔 | liquid |
| JAVLOR | Vinflunine | injection |
| JAVLOR | Vinflunine | injection |
| JAVLOR | Vinflunine | injection |
| JAVLOR | Vinflunine | injection |
| JAVLOR | Vinflunine | injection |
| JAVLOR | Vinflunine | injection |
| MEKTOVI | Binimetinib | tablet |
| MEKTOVI | Binimetinib | tablet |
| MEKTOVI | Binimetinib | tablet |
| Nerlynx | Neratinib | tablet |
| Obgemsa 75mg tablets | Vibegron | tablet |
EU
Source: www.ema.europa.eu
| Brand | Active ingredient(s) | Form |
|---|---|---|
| BUSILVEX | 白消安 | unknown |
| Ebvallo | Tabelecleucel | unknown |
| HEMANGIOL | 盐酸普萘洛尔 | unknown |
| JAVLOR | Vinflunine | unknown |
| Obgemsa 75mg tablets | Vibegron | unknown |